Change of Address

VEVENU

Glaxo Group Limited

Change Of Correspondence Address

The table below presents the data as entered.

Input Field	Entered
SERIAL NUMBER	77112708
LAW OFFICE ASSIGNED	LAW OFFICE 114
MARK SECTION
MARK	VEVENU
CORRESPONDENCE SECTION (current)
ORIGINAL ADDRESS	Maribeth Day Case GlaxoSmithKline Five Moore Drive MAI-B.443 Research Triangle Park North Carolina 27709 United States 919-483-1803 704-625-9190 rtp_tm-trademarks@gsk.com
NEW CORRESPONDENCE ADDRESS
NEW ADDRESS	Maribeth Day Case GlaxoSmithKline Five Moore Drive LGTM, MAI.B475-D Research Triangle Park North Carolina United States 27709 919 483 1803 704 625 9190 trademarks@gsk.com
SIGNATURE SECTION
SIGNATURE	/Maribeth Day Case/
SIGNATORY NAME	Maribeth Day Case
SIGNATORY DATE	10/27/2009
SIGNATORY POSITION	Attorney-in-Fact/ Director and Trademark Counsel
AUTHORIZED SIGNATORY	YES
FILING INFORMATION SECTION
SUBMIT DATE	Wed Oct 28 09:51:22 EDT 2009
TEAS STAMP	USPTO/CCA-XXX.X.XX.X-2009 1028095122356588-78729601 -46027f0762c919260117042f 5228bfbe733-N/A-N/A-20091 026213520645592

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.